Oncocross Revenue

In the year 2025, Oncocross had annual revenue of 370.46M KRW, down -65.45%. Oncocross had revenue of 140.93M in the quarter ending December 31, 2025, a decrease of -78.49%.

Revenue

370.46M

Revenue Growth

-65.45%

P/S Ratio

301.23

Revenue / Employee

n/a

Employees

n/a

Market Cap

111.59B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	370.46M	-701.74M	-65.45%
Dec 31, 2024	1.07B	980.68M	1,071.49%
Dec 31, 2023	91.52M	-58.72M	-39.08%
Dec 31, 2022	150.25M	50.25M	50.25%
Dec 31, 2021	100.00M	10.00M	11.11%
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
IMB Dx	5.33B
CG Invites	27.39B
iNtRON Biotechnology	5.74B
GeneOne Life Science	23.04B
Amicogen	41.98B
ORIENT BIO	59.09B
ENCell	5.26B
Vaxcell-Bio Therapeutics	1.90B

Revenue Rankings